News
A New Senate & its implications on The Pharmaceutical Sector?
The US elections make big news whenever they occur. The fact that who comes to power has a phenomenal effect on all industries, big or...
News
AstraZeneca Says Calquence Approved In The EU For CLL
AstraZeneca’s Calquence (acalabrutinib), a next-generation selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in the European Union (EU) for the treatment of adult patients...
News
Novavax COVID-19 Vaccine Granted Fast Track Designation by U.S. FDA
Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced that the U.S. FDA has granted Fast Track Designation for NVX-CoV2373,...
News
Llama nanobodies could be a powerful weapon against COVID-19
The researchers at the University of Pittsburgh School of Medicine describe a new method to extract tiny but extremely powerful SARS-CoV-2 antibody fragments from llamas,...
Drug Research
Oxford Biomedica and PhoreMost enter gene therapy discovery collaboration
Oxford Biomedica plc , a leading gene and cell therapy group and PhoreMost Limited, the UK-based biopharmaceutical company dedicated to developing drugs against intractable disease...
News
CDMOs benefit from COVID-19 impacts but mega-cap pharma innovation slowing outsourcing according to CPhI Annual Report
The global contact services sector is benefiting from a switch towards COVID-19 manufacturing (vaccine and therapy) and clinical stage contracts, but mega-cap innovator drug approvals...
Clinical Trials
Pfizer Announces Positive Phase 3 Study Results for XELJANZ in Ankylosing Spondylitis
Pfizer Inc. announced positive results from a Phase 3 investigational study evaluating the safety and efficacy of tofacitinib in adults with active ankylosing spondylitis (AS)....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.